DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

Soleus Capital Management, L.P.'s Holding History (CIK: 0001802630)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 182,110 Value ($000) $2,548 Avg Close $14.07 Range $10.57 - $16.97

Q1 2025

Shares 135,000 Value ($000) $1,835 Avg Close $19.16 Range $13.30 - $24.34

Q1 2024

Shares 47,000 Value ($000) $964 Avg Close $18.79 Range $15.49 - $23.52

Q4 2023

Shares 130,000 Value ($000) $2,790 Avg Close $19.81 Range $15.45 - $23.81

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	182,110	$2,548	$14.07	$10.57 - $16.97
Q1 2025	135,000	$1,835	$19.16	$13.30 - $24.34
Q1 2024	47,000	$964	$18.79	$15.49 - $23.52
Q4 2023	130,000	$2,790	$19.81	$15.45 - $23.81